GCG’s Q2 2023 Healthcare Industry Update provides an overview of the latest trends in the sector, including recent performance, valuation multiples, and the state of the middle-market M&A environment.

Key findings include the following:

• Q2 2023 saw mixed performance in public equities across the Healthcare landscape compared to the broader equity market. Healthcare investors are experiencing intensified competition for investment opportunities, increased interest rates from the Fed, a surge in labor costs, stricter lending conditions, and more recently, uncertainties resulting from disruptions in the banking sector.
• Q2 2023 middle-market M&A deal volume and average deal value increased from Q1 2023. Labor market conditions are shifting favorably for employers in Q2 as IT and administrative layoffs ramp up.
• The Biotechnology category led transaction activity, accounting for 23.2% of total Healthcare volume. Healthcare Technology and Healthcare Services sectors were also strong in Q2 with 20.3% and 17.5% of transaction volume.

Click here for the full update.

See here for all Healthcare News and Updates

Get in Touch

Tell us a little about yourself and we will get in touch as soon as we can.